Cartesian Therapeutics management to participate in upcoming investor conferences
Cartesian Therapeutics said management expects to participate in upcoming investor conferences, as part of the company’s planned engagement schedule.
FREDERICK, Md., Sept.
03, 2026 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc.
NASDAQ:RNAC (the “Company”), a late clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced that its management expects to participate in the following investor conferences…